2B4: A potential target in Staphylococcus aureus associated allergic inflammation

Area of Science:

• Immunology
• Molecular Biology
• Microbiology

Background:

• Staphylococcus aureus (SA) and its exotoxins activate immune cells via CD48.
• 2B4 (CD244) is a high-affinity ligand for CD48, expressed on various leukocytes.
• CD48-2B4 binding is crucial in eosinophil and mast cell interactions.

Purpose of the Study:

• To investigate if SA exotoxins, specifically Staphylococcus enterotoxin B (SEB), bind to and activate the 2B4 receptor.
• To explore the role of the SEB-2B4 interaction in inflammation.
• To assess the therapeutic potential of targeting the 2B4 receptor in SA-associated inflammatory conditions.

Main Methods:

• Enzyme-linked immunosorbent assay (ELISA) and flow cytometry (FC) to detect SEB binding to 2B4.
• Fluorescence microscopy and microscale thermophoresis for binding analysis.
• In vitro eosinophil activation assays and in vivo SEB-induced peritonitis model in 2B4 knockout (KO) mice.

Main Results:

• SEB specifically binds to the 2B4 receptor.
• The SEB-2B4 interaction triggers eosinophil activation.
• Computational modeling identified potential SEB binding sites on 2B4.
• 2B4-KO mice exhibited reduced inflammation in an SEB-induced peritonitis model compared to wild-type (WT) mice.

Conclusions:

• 2B4 is a key receptor mediating SEB-induced inflammation.
• The SEB-2B4 interaction contributes to SA-associated inflammatory conditions.
• Targeting 2B4 may offer a therapeutic strategy for managing SA-related inflammation.